| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 29 May 2025 | 22 May 2025 |
| To consider and approve the financial results for the period ended March 31, 2025 and other business matters Zenith Drugs Limited has informed the Exchange regarding Board meeting held on May 29, 2025. (As Per NSE Announcement Dated On : 29.05.2025) | ||
| Board Meeting | 17 Apr 2025 | 3 Apr 2025 |
| 1. To assess the proposal for raising funds to enhance the Companys financial resources.2. To increase the Authorized Share Capital of the Company and consequent alteration in Memorandum of Association of the Company. The Company has informed the Exchange that a Board meeting to be held on April 12, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on April 17, 2025, To consider Fund Raising and other business matters (As Per NSE Announcement Dated on 12.04.2025) Zenith Drugs Limited has informed the Exchange regarding Cancellation of Board Meeting dated April 17, 2025.. (As Per NSE Announcement Dated on 17.04.2025) | ||
| Board Meeting | 14 Nov 2024 | 9 Nov 2024 |
| To consider and approve the financial results for the period ended September 30, 2024 Zenith Drugs Limited has informed the Exchange regarding Board meeting held on November 14, 2024. (As Per NSE Announcement Dated on: 14/11/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.